Shares of several pharmaceutical companies were up after President Trump signed an executive order aimed at accelerating research, development access to psychedelic medicines for the treatment of ...

We'll know more about the company's medium-term prospects by the end of the year.

If biotech funding continues to increase this year, Danaher could benefit.

On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...

In this article, we will look at the 8 Most Undervalued Biotech Stocks to Buy Right Now.

This oncology-focused biotech, advancing multiple clinical-stage therapeutics, just reported a notable insider sale in recent ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...

The volatile biotech industry has put up a strong performance in 2025 despite the uncertain macroeconomic environment. While the tariff saga hit the pharma/biotech industry earlier in the year, the ...

Legend Biotech Corporation (NASDAQ:LEGN) is one of the 10 Overlooked Growth Stocks to Buy Now. Legend Biotech Corporation ...

RTW Biotech Opportunities (RTW:$2.27), a specialist healthcare investor in innovative biotech and medtech companies, ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Healthcare and biotech stocks have had a rough run since the giddy heights of the Covid pandemic.

Biotech stocks saw a major rebound in 2025, with key indexes significantly outperforming the S&P 500. Private investment in longevity science doubled in 2024, highlighting growing interest in ...